Haller, Hermann

Haller, Hermann, Prof. Dr. med.

Division of Nephrology

Hannover Medical School
Carl-Neuberg-Str. 1
30625 Hannover


Biography / About

Date of Birth:April, 1953
Function:Full Professor and Chair, Division of Nephrology, Hannover Medical School (MHH)


1976 - 1979History of Arts, FU Berlin
1976 - 1982Medical school, FU Berlin
1982MD at the Free University Berlin, Department of Endocrinology
1982Approbation – Medical License
1982 - 1992Internal Medicine, University Hospital Benjamin Franklin, FU Berlin
1987 - 1989Postdoctoral Research Fellow, Yale University, Medical School, Division of Endocrinology (Prof. H. Rasmussen)
1991Residency Internal Medicine (24.10.1991)
1998Residency Nephrologist (18.03.1998)
1992Post-doctoral lecturing qualification, Internal Medicine (FU Berlin), “Molecular mechanisms of cardiovascular hypertrophy“

Academic appointments and Research posts:

1991 - 1993Assistant Professor of Medicine, University Clinic Benjamin Franklin, Berlin
1992 - 1999Vice-Director, Division of Nephrology, Franz-Volhard-Clinic, Humboldt-University Berlin
1993 - 1999Associate (C3) Professor, Humboldt-University Berlin and Coordinator: Research Area Hypertension, Max-Delbrück-Centrum für Molekulare Medizin (MDC), Berlin-Buch
Since 1999Director, Department of Nephrology and Hypertension, MHH
2002 - 2011Dean of Medical Education (Studiendekan), MHH
Since 2007Coordinator: Integrated research and treatment centre for transplantation (IFB), MHH
Since 2007Faculty of the MDIBL – Mount Desert Island Biological Laboratory
Since 2011Honorary Professor of Huazhong University of Science and Technology in Wuhan, China
Since 2011Director of Sino-German Clinical Trial Centre of Tongji Hospital
Since 2014Head of Management of International Affairs, MHH

Awards and Prizes:

1994Franz Volhard Prize of the Society of Nephrology
1996Walter Clawitter Prize of the Heinrich Heine University, Düsseldorf
2000Franz Volhard Prize, German Hypertension Society
2005Björn Folkow Award, European Society of Hypertension
2007Jan Brod Prize, Czech Society of Hypertension
2010Prize of the German Lodge of Druidism
2014„Wennerström Lecture“ of Göteburg Sahlgrenska University Hospital

Major research interests:

  • Pathogenesis and consequences of hypertension
  • Kidney and vessel injury and regeneration

Selected Publications:

  1. Hegermann J, Lünsdorf H, Ochs M, Haller H. Visualization of the glomerular endothelial glycocalyx by electron microscopy using cationic colloidal thorium dioxide. Histochem Cell Biol. 2016 Jan;145(1):41-51.
  2. Schiffer M, Teng B, Gu C, Shchedrina VA, Kasaikina M, Pham VA, Hanke N, Rong S, Gueler F, Schroder P, Tossidou I, Park JK, Staggs L, Haller H, Erschow S, Hilfiker-Kleiner D, Wei C, Chen C, Tardi N, Hakroush S, Selig MK, Vasilyev A, Merscher S, Reiser J, Sever S. Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models. Nat Med. 2015 May 11. doi: 10.1038/nm.3843. [Epub ahead of print]
  3. Wang L, Balzer MS, Rong S, Menne J, von Vietinghoff S, Dong L, Gueler F, Jang MS, Xu G, Timrott K, Tkachuk S, Hiss M, Haller H, Shushakova N. Protein kinase C α inhibition prevents peritoneal damage in a mouse model of chronic peritoneal exposure to high-glucose dialysate: Kidney Int. 2016 Jun;89(6):1253-67
  4. Korstanje R, Deutsch K, Bolanos-Palmieri P, Hanke N, Schroder P, Staggs L, Bräsen JH, Roberts IS, Sheehan S, Savage H, Haller H, Schiffer M. Loss of Kynurenine 3-Mono-oxygenase Causes Proteinuria. J Am Soc Nephrol. 2016 Nov;27(11):3271-3277.
  5. Menne J, Eulberg D, Beyer D, Baumann M, Saudek F, Valkusz Z, Więcek A, Haller H; Emapticap Study Group. C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria. Nephrol Dial Transplant. 2017 Feb 1;32(2):307-315
  6. Meier M, Park JK, Overheu D, Kirsch T, Lindschau C, Gueler F, Leitges M, Menne J, Haller H. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozoticin-induced diabetic mouse model.Diabetes. 2007 Feb;56(2):346-54.
  7. Meier M, Menne J, Park JK, Holtz M, Gueler F, Kirsch T, Schiffer M, Mengel M, Lindschau C, Leitges M, Haller H. Deletion of protein kinase C-epsilon signaling pathway induces glomerulosclerosis and tubulointerstitial fibrosis in vivo.J Am Soc Nephrol. 2007 Apr;18(4):1190-8.
  8. Radermacher J, Mengel M, Ellis S, Stuht S, Hiss M, Schwarz A, Eisenberg U, Burg M, Luft FC, Gwinner W, Haller H. The renal arterial resistance index and renal allograft survival. N Engl J Med. 2003 Jul 10; 349(2):115-24.
  9. Elger M, Hentschel H, Litteral J, Wellner M, Kirsch T, Luft FC, Haller H. Nephrogenesis Is induced by Partial Nephrectomy in the Elasmobranch Leucoraja erinacea. J Am Soc Nephrol. 2003 Jun; 14(6):1506-18.
  10. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, Galanski M, Koch KM, Haller H. Use of Doppler Ultrasonography to Predict the Outcome of Therapy for Renal-Artery Stenosis. N Engl J Med. 2001; 344(6):410-417.

[back to listing]
This website uses cookies and the web analytics service Google Analytics. Click here for further information on privacy.
I agree